Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
British Journal of Haematology|June 26, 2020
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105)Dai Maruyama, Shinsuke Iida, Gakuto Ogawa, et al.
Annals of Hematology|January 11, 2021
A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulinTetsuya Nishida, Takeshi Kobayashi, Masashi Sawa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2019
Prospective Phase 2 Study of Umbilical Cord Blood Transplantation in Adult Acute Leukemia and Myelodysplastic SyndromeSeitaro Terakura, Tetsuya Nishida, Masashi Sawa, et al.
Blood|May 5, 2023
The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axisKazuaki Kameda, Ryo Yanagiya, Yuji Miyatake, et al.
Hematological Oncology|February 10, 2022
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphomaKana Miyazaki, Ritsuro Suzuki, Masahiko Oguchi, et al.
Cancer Chemotherapy and Pharmacology|January 24, 2025
Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1)Masaki Ri, Shinsuke Iida, Kosuke Saito, et al.
Bone Marrow Transplantation|March 24, 2020
Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndromeSeitaro Terakura, Tetsuya Nishida, Masashi Sawa, et al.
Japanese Journal of Clinical Oncology|September 2, 2025
Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphomaKen Ohmachi, Tomohiro Kinoshita, Dai Maruyama, et al.
The Lancet. Haematology|May 25, 2024
Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 studyJehan Dupuis, Emmanuel Bachy, Franck Morschhauser, et al.
Cancer Science|June 30, 2018
R-High-CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDYMichinori Ogura, Kazuhito Yamamoto, Yasuo Morishima, et al.
Pageof 17